Middle East Medical Cannabis Market, by Distribution Channel

Growth Outlook

• The Middle East Medical Cannabis Market, by Distribution Channel market is on a steady long-term growth path. Segment value stands at roughly USD 37 Mn in 2026 and is projected to reach USD 45 Mn by 2027 — a gain of about 22% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Hospital pharmacy leads, holding roughly 56% of segment value — the single largest regional share. Retail Pharamcy is the second-largest contributor. Online Pharmacy make up the remainder, in descending order.
• By 2027, Hospital pharmacy alone is expected to reach USD 25 Mn, with Retail Pharamcy at USD 13 Mn.

Market Dynamics

The Middle East region, comprising of countries such as Saudi Arabia, United Arab Emirates, Qatar, and Kuwait, is rapidly emerging as a potential market for medical cannabis. The demand for medical cannabis in this region is primarily driven by the increasing acceptance and legalization of cannabis for medical use, as well as the growing awareness among the population about the potential benefits of cannabis in treating various medical conditions.

One of the key factors contributing to the demand for medical cannabis in the Middle East is the increasing prevalence of chronic diseases such as cancer, epilepsy, multiple sclerosis, and Crohn's disease. These conditions often cause severe pain and discomfort for patients, and traditional medication may not always provide sufficient relief. As a result, patients are turning to medical cannabis as an alternative treatment option, leading to a rise in demand.

In addition, the Middle East region has a large population of elderly individuals, who are more susceptible to age-related health issues such as arthritis and chronic pain. Many elderly patients are also seeking natural and holistic remedies to manage their symptoms, and medical cannabis has proven to be an effective option for them.

The distribution channel for medical cannabis in the Middle East is primarily through pharmacies and hospitals. Pharmacies are the most accessible and convenient option for patients to access medical cannabis, as they are widely available in the region. Most pharmacists in the Middle East are trained to dispense prescription drugs, including medical cannabis, and are well-informed about its therapeutic properties and usage.

Hospitals, on the other hand, are also playing a crucial role in the distribution of medical cannabis in the Middle East. With the increasing acceptance of medical cannabis, more hospitals are offering it as a treatment option for their patients. This has led to a rise in demand for medical cannabis from hospitals, as patients trust the medical professionals to prescribe them the appropriate dosage and supervision.

In conclusion, the demand for medical cannabis in the Middle East is driven by the increasing prevalence of chronic diseases and the aging population, which is looking for alternative treatment options. The distribution of medical cannabis through pharmacies and hospitals has made it more accessible to patients in this region. As the legal and social barriers towards medical cannabis continue to break down, the demand for it is expected to grow even further in the Middle East in the coming years.